Last reviewed · How we verify
TECHNETIUM GLUCEPTATE
TECHNETIUM GLUCEPTATE is a drug. It is currently FDA-approved (first approved 1978).
At a glance
| Generic name | TECHNETIUM GLUCEPTATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1978 |
Approved indications
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TECHNETIUM GLUCEPTATE CI brief — competitive landscape report
- TECHNETIUM GLUCEPTATE updates RSS · CI watch RSS
Frequently asked questions about TECHNETIUM GLUCEPTATE
What is TECHNETIUM GLUCEPTATE?
TECHNETIUM GLUCEPTATE is a Small molecule drug.
When was TECHNETIUM GLUCEPTATE approved?
TECHNETIUM GLUCEPTATE was first approved on 1978.
What development phase is TECHNETIUM GLUCEPTATE in?
TECHNETIUM GLUCEPTATE is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing